Nello Mainolfi - 01 Jul 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: KYMR
Reported as of: 01 Jul 2024
Net transaction value: +$100,060
SEC form: 4
Accepted by SEC: 01 Jul 2024, 16:30:10 UTC
Prior SEC filing: 20 Jun 2024
Next SEC filing: 13 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Bruce N. Jacobs, as Attorney-in-Fact

Key filing fact

Nello Mainolfi filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 01 Jul 2024.

Key facts

This page summarizes Nello Mainolfi's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2024, 16:30.

Change

Previous filing in this sequence was filed on 20 Jun 2024.
Current net transaction value: +$100,060.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYMR transaction

Common Stock

Options Exercise

Transaction value: $100,060
Shares: +18,773
Change %: +3%
Price: $5.33^*
Shares after: 649,959
Date: 01 Jul 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KYMR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -18,773
Change %: -6.1%
Price: $0.000000
Shares after: 288,456
Date: 01 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,773
Exercise price: $5.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of May 14, 2020, subject to the reporting person's continued employment through each vesting date.